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administrated bupivacaine resulted in clinically relevant PVRs based on impaired detrusor function. The
addition of fentanyl enhanced this effect without generating greater PVRs. After surgery, the voiding
phase was not further impaired; however, bladder compliance was decreased.
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ABSTRACT
Background: More than 5 million patients receive eryth-
rocyte transfusions in the United States every year. Previous 
studies linked the storage duration of allogeneic erythrocytes 
to the risk of severe postoperative complications, especially 
after cardiac or trauma surgery. Limited data are available 
for noncardiac surgical patients. We therefore evaluated the 
association between storage duration of transfused erythro-
cytes and postoperative all-cause mortality among general 
surgery patients.
Methods: Perioperative data corresponding to 63,319 adult, 
general surgery patients were obtained from our registry and 
merged with blood product data. Patients receiving solely 
leukocyte-reduced, allogeneic erythrocyte transfusions were 
included. Multivariable Cox proportional hazards regression 
was used to characterize the relationship between median 
erythrocyte storage duration and postoperative mortality 
rate, adjusting for characteristics plausibly influencing the 
storage duration of erythrocytes.
Results: Of the 6,994 patients included in the final analysis, 
23, 44, 11, 9, and 13% received 1, 2, 3, 4, and ≥5 eryth-
rocyte units, respectively. The authors found no evidence 
that increasing median storage duration was associated with 
a difference in the risk of postoperative mortality (hazard 
ratio, 0.99 [0.94–1.04]; P = 0.64). Analyzing the mean stor-
age duration of erythrocyte units as a function of year of 
transfusion, the authors demonstrate a relevant decrease in 
utilization of the oldest blood units, whereas young blood 
storage duration remains nearly unchanged.
Conclusion: The authors’ study supports the recent lit-
erature in surgical and medical patients and underlines the 
importance of sufficiently powered randomized trials to 
finally resolve the erythrocyte storage duration debate.
S INCE the discovery of circulation by Sir William Har-vey, M.D. (Lumleian Lecturer, Royal College of Phy-
sicians and St. Bartholomew Hospital, London, England) 
(1578–1657) in the early 17th century, and the subsequent 
first successful intraoperative blood transfusion by George 
Washington Crile, M.D. (Professor of Clinical Surgery in 
the Western Reserve Medical College, Cleveland, OH) 
(1864–1943) at the Cleveland Clinic,1,2 blood transfusions 
are important therapeutic agents. In the United States, more 
than 5 million patients receive erythrocytes every year.** 
Transfusions, specifically numbers of erythrocyte units, have 
been associated with severe adverse outcomes, including 
increased risk for infections,3–5 pulmonary complications6, 
and cancer recurrence,7,8 and prolonged intensive care 
unit4,5,9 and hospital length of stay.5,9
In recent years, the storage duration of allogeneic eryth-
rocytes has been linked to the risk of severe postoperative 
complications, especially after cardiac surgery.10,11 Time-
dependent changes in the biochemical properties of stored 
erythrocytes collectively referred to as the “storage lesion,” 
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What We Already Know about This Topic
•	 Transfusion	of	blood	with	a	longer	storage	time	has	been	as-
sociated	with	increased	mortality	in	cardiac	surgery	patients,	
but	 studies	 outside	 this	 setting	 have	 been	 small	 and	 with	
mixed	results
What This Article Tells Us That Is New
•	 In	a	study	of	nearly	7,000	patients	receiving	transfusions	for	
noncardiac	 surgery,	 there	was	no	 relationship	between	me-
dian	storage	duration	time	and	mortality
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have been proposed as the underlying mechanism.12,13 These 
changes include alterations in the erythrocyte membrane and 
decreases in 2,3 diphosphoglycerate, nitric oxide, and intra-
cellular potassium concentrations.14 Storage lesion changes 
result in compromised in vitro erythrocyte function and 
viability.12,15–17 However, the effect of these observed changes 
on clinical outcomes of transfused patients remains unclear.
Some studies show a significant association between stor-
age duration of erythrocyte units and adverse outcomes, 
including mortality, hospital length of stay, intubation 
time, infectious complications, multiorgan failure, and 
composites of adverse events.11,14,18,19 Other studies show 
no association or only minor associations that were largely 
attributed to increased baseline risk in transfused patients 
rather than to the effects of older transfused cells per se.19–21 
Interpretation of these studies is complicated by use of dif-
ferent methodological and analytical approaches, not all of 
which adequately adjust for confounding factors and disease 
severity. Most studies performed to date were in the cardiac 
surgery, intensive care, and trauma populations. Limited 
data are available for noncardiac surgical patients.7,22,23 We 
thus sought to evaluate whether or not storage duration of 
transfused erythrocytes is associated with postoperative all-
cause mortality among noncardiac surgery patients using 
data derived from the Cleveland Clinic Perioperative Health 
Documentation System registry.
Materials and Methods
With approval from the Cleveland Clinic Institutional 
Review Board (Cleveland, OH), perioperative data corre-
sponding to 63,319 adult, American Society of Anesthesi-
ologists Physical Classification I–V, general surgery patients 
treated at Cleveland Clinic between January 6, 2005, and 
June 30, 2009, were obtained from our Perioperative Health 
Documentation System registry. Erythrocyte transfusion 
and product data were obtained from the laboratory infor-
mation system. Patients receiving leukocyte-reduced allo-
geneic erythrocyte transfusions between 2 days before the 
date of surgery and 7 days afterward were included in the 
study. Only the most recent operation for each patient was 
analyzed. Postoperative mortality information in our Periop-
erative Health Documentation System registry was obtained 
by combining data from both hospital records and the U.S. 
Social Security Administration’s Death Master File. The 
U.S. Social Security Administration’s Death Master File was 
queried on June 15, 2011, matching patients on their social 
security numbers. Patients for whom long-term death infor-
mation was not available from the Death Master File were 
censored at hospital discharge.
Erythrocyte storage duration as an exposure is compli-
cated because patients potentially receive multiple units and 
thus are exposed to multiple storage durations but can expe-
rience only one mortality outcome. Koch et al.,11 in a study 
evaluating the association between storage duration and 
mortality among cardiac surgery patients, created two groups 
by splitting the overall distribution of erythrocyte storage 
duration at the observed median of 14 days. This approach 
is useful for studying whether or not there is evidence of 
an overall association but does not provide an assessment of 
dose–response. With this latter goal in mind, we character-
ized the storage duration exposure using the median storage 
duration of all erythrocyte units transfused to a patient. But 
to keep the groups homogeneous, we excluded patients for 
whom the range of storage duration among transfused units 
exceeded 5 days.
Statistical Methods
First, we grouped patients into three storage duration groups 
based on whether their median storage duration was ≤14 
days, >14 days but ≤28 days, or >28 days. Kaplan–Meier 
survival density function estimates were then obtained and 
plotted for each of the three groups.24 Although this analysis 
is useful for visualizing patterns of survival, it does not adjust 
for potential confounding factors. Therefore, no testing for 
differences was undertaken in this exploratory analysis.
For the primary hypothesis, multivariable Cox 
proportional hazards regression was used to characterize 
the relationship between median erythrocyte storage 
duration and postoperative mortality rate over time. We 
adjusted for any patient and surgical characteristic plausibly 
influencing the storage duration of erythrocytes. Previous 
studies have been criticized for inadequately considering 
baseline parameters such as patient comorbidities. We 
cannot plausibly postulate a mechanism that would explain 
how older blood might get assigned to particular subgroups 
of patients. Blood banks are typically unaware of patient 
characteristics, and standard operating procedures require 
using the oldest available matching. We did adjust for blood 
type of the patient, Rhesus factor of the patient, number 
of units transfused, range of storage duration among the 
transfused erythrocyte units within a patient, and date of 
surgery.25
First, we developed a Cox model whereby the relation-
ship was modeled flexibly via a smoothing procedure (specif-
ically, penalized B-spline smoothing).26 Covariate-adjusted 
mortality incidence estimates (at several fixed postoperative 
times: up to 2 yr postoperatively) were then obtained and 
graphed as a function of patient-median erythrocyte storage 
duration using this model. Nonlinearity of the relationship 
(between patient-median erythrocyte storage duration and 
the logarithm of the hazard rate) was tested for significance 
using a Wald chi-squared test. If no significant evidence of 
nonlinearity was found, we used a simpler linear model to 
describe the relationship.
Adequacy of the assumption of proportional hazards 
across postoperative time for our final model was assessed 
using various graphical and analytic methods (e.g., a plot 
of log-cumulative hazards against log-time, Schoenfeld 
residual plots, and chi-squared tests for consistency of Cox 
model coefficients over time).27,28 R statistical software 
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version 2.1 2.1 for 64-bit Windows (The R Foundation for 
Statistical Computing, Vienna, Austria) was used for the 
statistical analysis. The Type I error rate for all hypotheses 
was fixed at 5%.
Results
Of the 63,319 surgical patients included in our study, 
10,090 (15.9%) were transfused with allogeneic erythro-
cyte products. We removed 314 patients who received one 
or more autologous erythrocyte units and an additional 
669 who received allogeneic erythrocyte units that were not 
leukocyte-reduced. Of the remaining 9,107 patients, 2,113 
(23.2%) received multiple units with storage duration rang-
ing greater than 5 days; removing these patients, we analyzed 
perioperative data on 19,462 allogeneic erythrocyte units 
transfused to 6,994 patients (fig. 1).
As expected, patients included in the analysis were gen-
erally sick, with 80% being assigned an American Soci-
ety of Anesthesiologists’ Physical Classification of III or 
above (table 1). Patients received anywhere between 1 and 
41 erythrocyte units; 23, 44, 11, 9, and 13% of patients 
received 1, 2, 3, 4, and ≥5 erythrocyte units, respectively. 
The patient-specific median erythrocyte storage duration 
was largely representative of the age of the individual units, 
with 94% of the units’ storage duration being within ±2 days 
of the respective patient medians. Overall, there were 1,718 
mortalities among the 6,994 patients analyzed (24.6%).
Estimated correlation (95% CI) between number of 
erythrocyte units transfused and median erythrocyte age 
was −0.10 (−0.13 to −0.08), indicating a slight relationship. 
Except for blood type and Rhesus factor—which are deter-
minants of blood product supply—we found little evidence 
of relationship between patients’ baseline characteristics and 
median erythrocyte storage duration. A summary of the 
top 15 principal procedures and diagnoses, as characterized 
by the U.S. Agency for Healthcare Research and Quality’s 
single-level Clinical Classifications Software (Agency for 
Healthcare Research and Quality, Rockville, MD), is pro-
vided in table 2.
Two-year U.S. Social Security Administration’s Death 
Master File data on mortality were available for 6,717 of 
6,994 patients; the remaining 4% were censored at dis-
charge. Kaplan–Meier survival density function estimates 
for three median erythrocyte storage duration groups are 
provided in figure 2; no appreciable differences between the 
three groups was evident. However, as stated in the Methods 
section, these results were not adjusted for potential con-
founders and were not compared statistically.
In our Cox regression modeling, we found no significant 
evidence of a nonlinear relationship between patient-
median erythrocyte storage duration and mortality after 
adjusting for potential confounders (fig 3, in red; P = 0.41, 
Wald chi-squared test). A simpler model that characterized 
the relationship linearly revealed similar conclusions: we 
found no evidence that increasing median storage duration 
was associated with a difference in the risk of postoperative 
mortality (P = 0.64), and based on this model, the 
hazard ratio (95% CI) corresponding to a relative 1-week 
increase in median erythrocyte storage duration was 0.99 
(0.94–1.04).
No evidence against the assumption of proportionality of 
the erythrocyte storage duration effect over time was found 
in our modeling (diagnostic graphics and tests not reported).
To assess possible changes in blood product management 
over time, we analyzed the mean storage duration of erythro-
cyte units as a function of year of transfusion. Figure 4 shows a 
relevant decrease in utilization of the oldest blood units, whereas 
young blood storage duration remains nearly unchanged.
Discussion
Over the past 10 yr, investigators have considered whether 
prolonged storage duration of erythrocyte units may worsen 
patient outcomes in surgical and nonsurgical patients. 
Unfortunately, despite a large body of research, divergent 
results have so far not led to a conclusive answer, and no 
consensus has been reached. We thus used our Periopera-
tive Health Documentation System to evaluate the relation-
ship between erythrocyte storage duration and postoperative 
all-cause mortality in a cohort of 6,994 patients receiving 
19,462 units of erythrocyte and undergoing general surgery. 
We did not find any association between erythrocyte storage 
duration and mortality and thus our study adds to the grow-
ing body of transfusion research, showing that erythrocyte 
age may not be associated with increased postoperative mor-
tality or morbidity.
Only few studies address the general surgical population 
and those are restricted to colon–rectal, prostate, and liver 
Fig. 1. Study flow diagram illustrating exclusion and inclusion 
of study population. ASA = American Society of Anesthesi-
ologists.
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Table 1. Summary of Baseline and Transfusion-related Patient Characteristics and Their Association with the Patient-
median Erythrocyte Age Exposure of Interest (N = 6,994)
Median (Quartiles)
Spearman Correlation Coefficient (95% 
CI) with Median Erythrocyte Storage 
Duration Exposure
Patient age, yr 66 (55–76) 0.01 (−0.01 to 0.03)
Body mass index, kg/m2 27 (23–32) −0.01 (−0.03 to 0.02)
Serum hematocrit, % 36 (31–41) 0.00 (−0.03 to 0.02)
Serum creatinine, mg/dl 0.9 (0.7–1.3) −0.01 (−0.03 to 0.02)
Case duration, min 266 (180–383) −0.04 (−0.06 to −0.02)
No. erythrocyte units transfused 2 (2–3) −0.10 (−0.13 to −0.08)
Range of erythrocyte product storage duration, d 0 (0–2) −0.02 (−0.04 to 0.00)
% of Patients Median (Quartiles) of Median Erythro-
cyte Storage Duration Exposure
Sex
 Male 46.0 15 (12–20)
 Female 54.0 16 (12–21)
Race
 White 82.8 16 (12–21)
 African American 14.2 16 (12–21)
 Other 3.0 15 (11–19)
ASA physical status
 I 0.8 15 (12–19)
 II 19.5 16 (12–21)
 III 59.5 16 (12–21)
 IV 19.7 15 (12–20)
 V 0.5 14 (12–17)
Hypertension
 No 52.4 16 (12–20)
 Yes 47.6 16 (12–21)
Chronic obstructive pulmonary disease
 No 86.3 16 (12–21)
 Yes 13.7 15 (12–20)
History of tobacco use or dependence
 No 82.7 16 (12–21)
 Yes 17.3 16 (12–21)
Diabetes mellitus
 No 82.1 16 (12–21)
 Yes 17.9 16 (12–21)
History of stroke
 No 98.8 16 (12–21)
 Yes 1.2 16 (13–20)
Peripheral vascular disease
 No 98.7 16 (12–21)
 Yes 1.3 16 (11–23)
Patient disposition
 Elective 87.9 16 (12–21)
 Emergent 12.1 16 (12–20)
Patient blood type
 A 41.0 18 (14–22)
 B 11.2 21 (16–26)
 O 44.1 13 (10–16)
 AB 3.6 17 (14–22)
Patient Rhesus factor
 Positive 86.3 15 (12–20)
 Negative 13.7 19 (14–24)
Comorbidity data in the Perioperative Health Documentation System (PHDS) is based on a combination of electronic medical record 
abstraction and billing data.
ASA = American Society of Anesthesiologists.
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transplant patients. For example, a study in 225 patients under-
going colon–rectal surgery showed that blood storage duration 
may, along with other risk factors, play a significant role in the 
development of postoperative infectious complications.23 The 
same group demonstrated a decrease in the incidence of cancer 
recurrence in colon–rectal patients receiving younger blood.7 
On the other hand, our group found that storage duration did 
not affect the incidence of cancer recurrence in patients after 
prostate surgery.22 In 405 patients receiving allogeneic transfu-
sions, the biochemical recurrence–free survival rate at 5 yr was 
74, 71, and 76% for those who received younger, middle, and 
older erythrocytes, respectively.22 Recent data from 526 patients 
undergoing orthotopic liver transplantation do not show an 
association between erythrocyte age with infection, organ rejec-
tion, and death.29
Over the past 10 yr, storage duration has received most 
attention in patients undergoing cardiac surgery. In one of the 
largest retrospective studies, also performed at the Cleveland 
Clinic, Koch et al.11 demonstrated an almost 60% percent 
increase in in-hospital mortality and significantly increased 
adverse events (cardiac, pulmonary, infectious, renal, and cere-
brovascular) in patients receiving older blood. Andreasen et 
al.10 investigated 1,748 patients undergoing coronary bypass 
graft surgery and found a significant relationship between 
blood product storage time and postoperative severe infec-
tions. More recent literature in the cardiac patient population 
could not identify any benefit of younger blood.30,31
Furthermore, in the largest study to date investigating 
storage duration in medical and surgical (cardiac and noncar-
diac) patients, Edgren et al.20 found no association between 
storage duration and mortality in more than 400,000 trans-
fused patients for any of the studied patient populations.
One problem with currently available literature in 
regards to erythrocyte duration is that almost all the studies 
Table 2. Top 15 Principal Diagnoses and Procedures (Based on ICD Discharge Codes)
N (%) of Patients
Top 15 Principal Diagnoses
 Osteoarthritis 704 (10.1)
 Complication of device; implant or graft 604 (8.6)
 Aortic; peripheral; visceral artery aneurysms 562 (8.0)
 Complications of surgical procedures or medical care 245 (3.5)
 Cancer of kidney and renal pelvis 244 (3.5)
 Spondylosis; intervertebral disc disorders; other back problems 236 (3.4)
 Secondary malignancies 224 (3.2)
 Cancer of bladder 196 (2.8)
 Other and unspecified benign neoplasm 160 (2.3)
 Regional enteritis and ulcerative colitis 160 (2.3)
 Other acquired deformities 147 (2.1)
 Peripheral and visceral atherosclerosis 129 (1.8)
 Cancer of colon 120 (1.7)
 Other gastrointestinal disorders 116 (1.7)
 Other bone disease and musculoskeletal deformities 111 (1.6)
 Other diagnoses 3,036 (43.4)
Top 15 Principal Procedures
 Hip replacement; total and partial 641 (9.2)
 Arthroplasty knee 544 (7.8)
 Aortic resection; replacement or anastomosis 501 (7.2)
 Colorectal resection 457 (6.5)
 Spinal fusion 430 (6.1)
 Nephrectomy; partial or complete 342 (4.9)
 Other OR gastrointestinal therapeutic procedures 321 (4.6)
 Other OR procedures on vessels other than head and neck 258 (3.7)
 Other OR therapeutic procedures of urinary tract 237 (3.4)
 Other organ transplantation 207 (3.0)
 Hysterectomy; abdominal and vaginal 206 (2.9)
 Other OR lower GI therapeutic procedures 184 (2.6)
 Incision and excision of CNS 172 (2.5)
 Open prostatectomy 141 (2.0)
 Amputation of lower extremity 131 (1.9)
 Other procedures 2,222 (31.8)
CNS = central nervous system; GI = gastrointestinal; ICD = International Classification of Diseases; OR = operating room.
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published so far are retrospective studies. It is likely that 
different statistical approaches contributed to the diver-
gent results. However, it is interesting to note, that most 
of the earlier research showed adverse effects of increased 
storage duration, whereas the newer studies do not see this 
association. In our study, like others previously, we adjusted for year 
of surgery, ABO-type, and the number of erythrocyte units 
transfused because these are true confounding factors (i.e., 
factors that might affect the likelihood of receiving older 
or younger blood). Other baseline characteristics, such as 
comorbidities and type of surgery, probably only influence 
the decision to transfuse per se rather than whether older or 
younger blood should be administered.
Our study, however, differs from previous ones, even 
from our own institution,11,32 in several ways. One difference 
is that we calculated storage duration based on the age range 
of units a patient received and excluded patients with ranges 
greater than 5 days. This period was chosen to enforce a 
degree of measurement precision regarding the storage dura-
tion assigned to each patient. We thereby excluded 23% of 
otherwise eligible patients from the analysis but increased 
homogeneity of our study population. A grouping approach 
using predefined storage duration cutoffs would have elimi-
nated a comparable number of patients.
A second difference is that we used storage duration as a 
continuous exposure rather than a dichotomous comparison 
for our primary analysis. This approach allowed us to address 
nonlinear time dependence. We found that postoperative 
mortality as a function of median storage duration for five 
specific snapshots in time (1, 3, and 6 months; 1 and 2 yr) 
does not change. It is thus not surprising that survival rates 
were similar when we divided our study population into three 
groups (patients receiving blood aged 3–14, 14.5–28, and 
28.5–42 days) as a secondary survival analysis.
Since the first published reports on a possible association 
between storage duration and adverse outcomes, transfusion 
Fig. 2. Kaplan–Meier survival density function estimates of 
postoperative mortality (and associated pointwise 95% CI) 
for three groups characterizing patient-median erythrocyte 
storage duration.
Fig. 3. Estimated incidence of mortality as a function of pa-
tient-median erythrocyte storage duration (in days) at various 
postoperative time points, up to 2 yr. In red is the pointwise 
95% CI representing mortality incidence from a Cox regres-
sion model in which the structure relationship was relaxed by 
using smoothing, whereas a standard linear Cox model esti-
mate (and pointwise 95% CI) is provided in black.
Fig. 4. Scatterplot of patient mean erythrocyte storage dura-
tion versus date of transfusion. Decile curves (estimated via 
quantile regression with a 4-degree-of-freedom natural cubic 
spline term for transfusion date) representing the distribution 
of storage duration over time are overlaid.
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practice might have changed. We therefore analyzed storage 
duration of erythrocytes as a function of the year of transfu-
sion. Figure 4 demonstrates a clear decrease in storage dura-
tion for the oldest units, whereas ages of the youngest units 
seem unchanged over the study period from 2005 to 2009. 
Cleveland Clinic did not change policies for blood prod-
uct selection and issue during this time period; therefore, 
the decrease in blood product age is most likely related to 
decreasing inventory levels combined with increasing or sus-
tained blood product usage. Furthermore, studies showing 
adverse outcomes associated with transfusion might have led 
to decreased utilization of transfusions, thus leading blood 
banks to adjust the number of units ordered from blood sup-
pliers and kept in store.
Because of the retrospective nature of our study, we were 
limited to investigate only the association between storage 
duration and mortality. It is important to note that there is a 
time lag between the date of death for an individual patient 
and when that fact is entered into the U.S. Social Security 
Administration’s Death Master File database. This delay at 
worst affected only a small portion of our sample and there-
fore has limited clinical relevance for our results. Currently, 
a number of prospective randomized trials investigating the 
relationship between storage duration and outcomes are 
underway, and results are anxiously awaited (ClinicalTrials.
gov Identifier NCT00991341; NCT00458783).33
Our results might be influenced by center-specific char-
acteristics, because data were collected at one site only. On 
the other hand, we included a fairly large number of patients 
with a broad spread of comorbidities who had a variety of 
surgical procedures. As is common in clinical practice, most 
of our patients were given a fairly small number of trans-
fusions. It is possible that many of our transfused patients 
did not have a true oxygen carrying or oxygen delivery defi-
ciency. Because poor outcome associated with storage lesion 
is thought to originate from impaired erythrocyte function 
or its effect on perfusion/oxygenation, it might not matter 
in patients with adequate oxygen delivery. It is thus possible 
that our results would differ in even sicker patients receiv-
ing larger numbers of erythrocytes. A possible effect in these 
specific patients could be postulated from studies in trauma 
patients showing a benefit from transfusion of younger 
erythrocytes.34 Unfortunately, our sample size was not large 
enough to perform a sensitivity analysis restricted to massive 
transfusions.
Another limitation of our study might be that we only 
evaluated mortality but not postoperative morbidity. Mor-
tality is a crude outcome, and it is most certainly possible 
that more intermediate outcomes might be more sensitive 
and benefit from younger blood. Subcutaneous tissue oxy-
gen tension and wound infection could function as inter-
mediate and clinical outcomes to demonstrate a storage 
age–related difference in oxygen delivery to tissues. Natural 
killer cell function might be used to assess possible impairing 
effects of storage duration on the patient’s immune function. 
We chose a 2-yr mortality outcome because of emerging lit-
erature suggesting long-term effects of intraoperative inter-
ventions on postoperative outcomes. However, it is feasible 
that our 2-yr outcome is affected by other events occurring 
between transfusion and the mortality ascertainment.
In summary, in our large retrospective study in adult gen-
eral surgical patients, we did not find an association between 
storage duration of erythrocytes and 2-yr mortality. This 
is in support of the majority of the most recent literature 
in surgical and medical patients. Our results represent yet 
another piece in a large puzzle and underline the importance 
of sufficiently powered randomized trials to finally resolve 
the erythrocyte storage duration debate.
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